# Neurological Diagnoses in Hospitalized COVID-19 Patients Associated With Adverse Outcomes: A Multinational Cohort Study

**Hutch, MR**, **Son J**, **Le TT**, **Hong C**, **Xuan W**, **Shakeri Z**, Morris M, Gutiérrez-Sacristán A, Klann G, Spiridou A, Bellazzi Riccardo, Benoit V, Bonzel C, Bryant WA, Cho K, Das P, Hanauer DA, Henderson DW, Ho YL, Loh W, Makoudjou A, Malovini A, Moal B, Mowery DL, Samayamuthu MJ, Sanz Vidorreta FJ, Schriver ER, Schubert P, Talbert J, Tan ALM, Tan BWL, Tan BWQ, Tibollo V, Yuan W, Avillach P, Gehlenborg N, Omenn GS, Characterization of COVID-19 by EHR (4CE), The Consortium for Clinical, **Visweswaran S**, **Cai T**, **Luo Y**, **Xia Z**.

---

A [Consortium for Clinical Characterization of COVID-19 by EHR](https://covidclinical.net/) study.

Our study leverages a multinational study of > 106,000 hospitalized COVID-19 adult and pediatric positive patients from 21 healthcare systems across 6 countries. We examined and report the clinical health outcomes (length of hospital stay and mortality) of COVID-19 patients with concurrent neurological illness. 

---

[Preprint Available](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4057133)

*Manuscript currently under review*

---

## View Code and Analysis

Explore the analysis using our interactive notebooks!

1. [Patient Characteristics](Patient-Characteristics.html)

2. [Meta-Analysis Cox-PH: Risk of Poor Health Outcomes](Meta-Analysis-Cox-PH.html)

---

To view the code and run the meta-analysis yourself, please see the [project repo!](https://github.com/covidclinical/Phase2.1NeuroAnalysis)
